Safety and Tolerability Study of Recombinant L-IFN Adenovirus Injection in Patients With Recurrent Glioblastoma
Clinical trial NCT05914935 · UNKNOWN
Trial details
- NCT number
- NCT05914935
- Sponsor
- Binhai Hospital of Fujian Medical University
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-27
- Primary completion
- 2024-06-12
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.